| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5498039 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 36 Pages |
Abstract
Concurrent neoadjuvant radiation added to radiosensitizing chemotherapy significantly improved pCR. A prospective randomized clinical trial is warranted to exploit the improved response seen with concurrent therapy but using another radio-sensitizing taxane, to better minimize treatment-related toxicity and determine its impact on overall survival.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Muriel MD, PhD, David MD, PhD, Alan B. MD, PhD, Leslie MD, Kylea MD, Theodore MD, Francisco MD, David MD, Donald MD, Anat MD, Giulio MD, Ann F. PhD,